Solvay Pharma Россия и СНГ Обратная связь Карта сайта
Суббота, 15 августа 2009 г.
Уже зарегистрировались 61752 пользователей
В стремлении к прогрессу, с заботой о людях
Инфлювак
Solmed
XV Российский национальный конгресс "Человек и лекарство"

Библиография

  1. Г. Г. Онищенко. Состояние вакцинопрофилактики в России и перспективы ее развития// Российские мед. вести МЗ РФ. № 4. 1998
  2. Ruben F. L. Who needs influenza vaccine? In: Options for the control of influenza. Kenclal A P, Patriarca P A eds. New York: Alan R Eiss, 1986: 139-134.
  3. Nicholson KG, Snacken R, Palache AM Influenza immunisation policies in Europe and the United States Vaccine 1995; 13: 365-369.
  4. Prevention and control of influenza. Recommendations of the Immunisation Practice AdvisoryCommittee (ACIP). Morbidity Mortality Wkly Rep 1994: 43: 1-13
  5. Fleming D. M. The impact of three influenza epidemics on primary care in England and Wales. PharmacoEconomics. 1996 In Press.
  6. Lui K., Kendal A P. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 1987: 77: 712-716.
  7. Williams W. W., Hickson M А, Каnе М A. et al. Immunisation policies and vaccine coverage among adults. Ann Int Mod 1988: 108: 616-625.
  8. Sprenger M. J. W., van Naelten M A M G, Mulder P G H, et al. Influenza mortality excess deaths in the elderly 1967-1982. Epidem Inf 1989; 103: 633-641.
  9. Sprenger M. J. W. The impact of Influenza: an epidemiological study of morbidity direct mortality and related mortality PhD Thesis, Erasmus University Rotterdam, 1990.
  10. Ghendon Y. Vaccination against influenza viruses: Current status. In: Viral vaccines. Advances in biotechnological proceses, volume 14. A Mizrahi ed. Wiley & Sons Inc. Publications 1990: 159-201.
  11. New vaccine development, establishing priorities I. Diseases of importance in the United States. Washington, Natl Acad Press 1985; 342.
  12. Barker W H. Excess pneumonia and influenza-associated hospitalisation during influenza epidemics in the United States. 1970-78. Am J Public Health 1986: 76:761-765.
  13. Sullivan KM Health Impact of Influenza in the United States PharmacoEconomics, 1996 In Press.
  14. Milne R. Influenza vaccination warrants a greater share of healthcare resources PharmacoResources 33: 3-5, 1995.
  15. WHO Memorandum from meeting in February 1995. Cell culture as a substrate for the production of influenza vaccines Bull WHO 1995; 73: 431-435.
  16. К. L. Nichol, K. L. Margolis, J. Wuorenma, T. Von Sternberg The efficacy and cost effectiveness of vaccination against Influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778-84.
  17. Schoenbaum S С. Economic impact of influenza: the individual's perspective. Am J Med 1987; 82 (suppl 6A): 26-30.
  18. Peter A. Gross, Alicia W. Hermogenes, Henry S. Sacks, Joseph Lau, Roland A. Levandowski The efficacy of Influenza vaccine in elderly persons. Ann Intern Med. 1995; 123:518-527.

Заказ через интернет



Solvay Pharma Реклама: Все о головокружении
Баннерная сеть Солвей-Фарма.ру
Адрес


Последнее обновление  15.08.2009 г.